{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Pentacel", "query": { "intervention": "Pentacel" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 20, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Pentacel&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-04T03:22:14.467Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02096263", "title": "Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Poliomyelitis", "Diphtheria", "Haemophilus Influenzae Type b", "Tetanus", "Acellular Pertussis", "Hepatitis B" ], "interventions": [ { "name": "Infanrix hexa", "type": "BIOLOGICAL" }, { "name": "Pediarix", "type": "BIOLOGICAL" }, { "name": "ActHIB", "type": "BIOLOGICAL" }, { "name": "Pentacel", "type": "BIOLOGICAL" }, { "name": "Engerix-B", "type": "BIOLOGICAL" }, { "name": "Infanrix", "type": "BIOLOGICAL" }, { "name": "Hiberix", "type": "BIOLOGICAL" }, { "name": "Prevnar13", "type": "BIOLOGICAL" }, { "name": "Rotarix", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "12 Weeks", "sex": "ALL", "summary": "6 Weeks to 12 Weeks" }, "enrollment_count": 585, "start_date": "2014-04-16", "completion_date": "2015-11-13", "has_results": true, "last_update_posted_date": "2019-11-27", "last_synced_at": "2026-09-04T03:22:14.467Z", "location_count": 43, "location_summary": "Tucson, Arizona • Fayetteville, Arkansas • Anaheim, California + 38 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Daly City", "state": "California" }, { "city": "Fresno", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02096263" }, { "nct_id": "NCT00804284", "title": "Database Surveillance Safety Study of PENTACEL® Vaccine", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Diphtheria", "Tetanus", "Pertussis", "Haemophilus Influenzae" ], "interventions": [ { "name": "DTaP-IPV/Hib", "type": "BIOLOGICAL" }, { "name": "Other DTap Vaccines", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "24 Months", "sex": "MALE", "summary": "6 Weeks to 24 Months · Male only" }, "enrollment_count": 62538, "start_date": "2008-09", "completion_date": "2015-01", "has_results": false, "last_update_posted_date": "2015-08-19", "last_synced_at": "2026-09-04T03:22:14.467Z", "location_count": 1, "location_summary": "Oakland, California", "locations": [ { "city": "Oakland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00804284" }, { "nct_id": "NCT06397768", "title": "Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "RSV Immunization" ], "interventions": [ { "name": "RSVt vaccine", "type": "BIOLOGICAL" }, { "name": "Diphtheria, tetanus, pertussis, poliomyelitis , Haemophilus influenzae type b, and hepatitis B vaccine", "type": "BIOLOGICAL" }, { "name": "Diphtheria, tetanus, pertussis, Haemophilus influenzae type b and poliomyelitis vaccine", "type": "BIOLOGICAL" }, { "name": "Hepatitis B vaccine", "type": "BIOLOGICAL" }, { "name": "Streptococcus pneumoniae vaccine", "type": "BIOLOGICAL" }, { "name": "Rotavirus vaccine", "type": "BIOLOGICAL" }, { "name": "Measles, mumps, and rubella vaccine", "type": "BIOLOGICAL" }, { "name": "Varicella virus vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Months", "maximum_age": "12 Months", "sex": "ALL", "summary": "6 Months to 12 Months" }, "enrollment_count": 2226, "start_date": "2024-05-13", "completion_date": "2025-09-18", "has_results": false, "last_update_posted_date": "2026-02-03", "last_synced_at": "2026-09-04T03:22:14.467Z", "location_count": 66, "location_summary": "Birmingham, Alabama • Grand Bay, Alabama • Mobile, Alabama + 55 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Grand Bay", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Bell Gardens", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06397768" }, { "nct_id": "NCT00467519", "title": "Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Tetanus", "Diphtheria", "Pertussis" ], "interventions": [ { "name": "Tdap (Tetanus Toxoid Reduced Diphtheria Toxoid/Acellular Pertussis)", "type": "BIOLOGICAL" }, { "name": "DTaP (Diphtheria & Tetanus Toxoids & Acellular Pertussis Adsorbed)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "4 Years", "maximum_age": "6 Years", "sex": "ALL", "summary": "4 Years to 6 Years" }, "enrollment_count": 1045, "start_date": "2007-04", "completion_date": "2009-12", "has_results": true, "last_update_posted_date": "2014-02-07", "last_synced_at": "2026-09-04T03:22:14.467Z", "location_count": 42, "location_summary": "Birmingham, Alabama • Fayetteville, Arkansas • Jonesboro, Arkansas + 34 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00467519" }, { "nct_id": "NCT01129362", "title": "Rates of Pertussis Disease Among Persons Receiving Pentacel® or Other Pertussis Vaccines", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pertussis" ], "interventions": [ { "name": "Pentacel® (DTaP-IPV/Hib)", "type": "BIOLOGICAL" }, { "name": "Other Pertussis Vaccines", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": "59 Months", "sex": "ALL", "summary": "Up to 59 Months" }, "enrollment_count": 1195, "start_date": "2010-02-08", "completion_date": "2014-12-30", "has_results": false, "last_update_posted_date": "2022-04-25", "last_synced_at": "2026-09-04T03:22:14.467Z", "location_count": 2, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" }, { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT01129362" }, { "nct_id": "NCT03537508", "title": "Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Healthy Volunteers (Meningococcal Infection)" ], "interventions": [ { "name": "MenACYW conjugate vaccine", "type": "BIOLOGICAL" }, { "name": "MenACYW-135 conjugate vaccine", "type": "BIOLOGICAL" }, { "name": "DTaP-IPV//Hib vaccine", "type": "BIOLOGICAL" }, { "name": "Pneumococcal 13-valent conjugate vaccine", "type": "BIOLOGICAL" }, { "name": "Pentavalent rotavirus vaccine", "type": "BIOLOGICAL" }, { "name": "Hepatitis B vaccine", "type": "BIOLOGICAL" }, { "name": "Measles, mumps, rubella (MMR) vaccine", "type": "BIOLOGICAL" }, { "name": "Varicella vaccine", "type": "BIOLOGICAL" }, { "name": "Hepatitis A vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "89 Days", "sex": "ALL", "summary": "42 Days to 89 Days" }, "enrollment_count": 2627, "start_date": "2018-04-25", "completion_date": "2023-09-22", "has_results": true, "last_update_posted_date": "2024-10-15", "last_synced_at": "2026-09-04T03:22:14.467Z", "location_count": 65, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Phoenix, Arizona + 54 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03537508" }, { "nct_id": "NCT00772928", "title": "Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diphtheria", "Tetanus", "Haemophilus Infection", "Pertussis", "Polio" ], "interventions": [ { "name": "Pentacel™: HCPDT-IPV//PRP-T Vaccine and Prevnar®", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "89 Days", "sex": "ALL", "summary": "42 Days to 89 Days" }, "enrollment_count": 1167, "start_date": "2003-10", "completion_date": "2006-11", "has_results": true, "last_update_posted_date": "2012-02-01", "last_synced_at": "2026-09-04T03:22:14.467Z", "location_count": 23, "location_summary": "Montgomery, Alabama • Fayetteville, Arkansas • Jonesboro, Arkansas + 19 more", "locations": [ { "city": "Montgomery", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00772928" }, { "nct_id": "NCT03893448", "title": "Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pneumococcal Infections", "Pneumococcal Vaccines" ], "interventions": [ { "name": "V114", "type": "BIOLOGICAL" }, { "name": "Prevnar 13™", "type": "BIOLOGICAL" }, { "name": "RotaTeq™", "type": "BIOLOGICAL" }, { "name": "Pentacel™", "type": "BIOLOGICAL" }, { "name": "RECOMBIVAX HB™", "type": "BIOLOGICAL" }, { "name": "VAQTA™", "type": "BIOLOGICAL" }, { "name": "MMR II™", "type": "BIOLOGICAL" }, { "name": "VARIVAX™", "type": "BIOLOGICAL" }, { "name": "HIBERIX™", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "90 Days", "sex": "ALL", "summary": "42 Days to 90 Days" }, "enrollment_count": 1720, "start_date": "2019-06-19", "completion_date": "2021-05-24", "has_results": true, "last_update_posted_date": "2023-07-28", "last_synced_at": "2026-09-04T03:22:14.467Z", "location_count": 66, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Opp, Alabama + 58 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Opp", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03893448" }, { "nct_id": "NCT03673462", "title": "Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Healthy Volunteers (Meningococcal Infection)" ], "interventions": [ { "name": "Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid Conjugate vaccine (MenACYW Conjugate vaccine)", "type": "BIOLOGICAL" }, { "name": "Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine (MENVEO®)", "type": "BIOLOGICAL" }, { "name": "Diphtheria, Tetanus, Acellular Pertussis, Poliovirus and Haemophilus b Vaccine", "type": "BIOLOGICAL" }, { "name": "Pneumococcal 13-valent Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "Rotavirus Vaccine", "type": "BIOLOGICAL" }, { "name": "Hepatitis B Vaccine", "type": "BIOLOGICAL" }, { "name": "Measles, Mumps, and Rubella Virus Vaccine", "type": "BIOLOGICAL" }, { "name": "Varicella Virus Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "89 Days", "sex": "ALL", "summary": "42 Days to 89 Days" }, "enrollment_count": 2797, "start_date": "2018-09-17", "completion_date": "2023-03-16", "has_results": true, "last_update_posted_date": "2023-12-14", "last_synced_at": "2026-09-04T03:22:14.467Z", "location_count": 67, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Phoenix, Arizona + 56 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Hot Springs", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03673462" }, { "nct_id": "NCT01000311", "title": "A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningococcal Disease" ], "interventions": [ { "name": "MenACWY-CRM", "type": "BIOLOGICAL" }, { "name": "DTaP-IPV/Hib", "type": "BIOLOGICAL" }, { "name": "HBV", "type": "BIOLOGICAL" }, { "name": "PCV", "type": "BIOLOGICAL" }, { "name": "MMR", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novartis Vaccines", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Days", "maximum_age": "89 Days", "sex": "ALL", "summary": "55 Days to 89 Days" }, "enrollment_count": 529, "start_date": "2009-11", "completion_date": "2011-11", "has_results": true, "last_update_posted_date": "2014-04-21", "last_synced_at": "2026-09-04T03:22:14.467Z", "location_count": 42, "location_summary": "Birmingham, Alabama • Fayetteville, Arkansas • Jonesboro, Arkansas + 33 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Canoga Park", "state": "California" }, { "city": "Fountain Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01000311" } ] }